Global Study Highlights Survival Benefit of Mogamulizumab in Advanced Cutaneous T-Cell Lymphoma Birmingham, UK, and Tokyo, Japan – Kyowa Kirin International (KKI), a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), a Japan-based global specialty pharmaceutical company,…
PureTech Health Presents New Phase 2b Analyses Demonstrating Consistent Safety and Efficacy of Deupirfenidone in Older Patients with Idiopathic Pulmonary Fibrosis Findings Highlight Potential for Deupirfenidone to Address a Critical Unmet Need in an Underserved Patient Population Boston, Mass. —…
GondolaBio’s PORT-77 Receives FDA Orphan Drug and Fast Track Designations for the Treatment of Erythropoietic Protoporphyria (EPP) and X-Linked Protoporphyria (XLP) CAMBRIDGE, Mass., [Month] [Day], 2025 — GondolaBio, a clinical-stage biopharmaceutical company pioneering novel therapies for patients living with serious…
Iambic Therapeutics and Jazz Pharmaceuticals Announce Research Collaboration to Evaluate IAM1363 and Zanidatamab Combination in HER2-Positive Breast Cancer SAN DIEGO, Calif., October 22, 2025 – Iambic Therapeutics, a clinical-stage life science and technology company pioneering the use of artificial intelligence…
Satellos Bioscience Doses First Adult Patient in LT-001, a Long-Term Follow-Up Study of SAT-3247 in Duchenne Muscular Dystroph Toronto, Ontario — [Insert Date], 2025 — Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a clinical-stage biotechnology company…
Merck Presents Systematic Review of Pneumococcal Serotypes Covered by CAPVAXIVE® in U.S. Adults Merck & Co., Inc., known as MSD outside the United States and Canada, announced findings from a systematic literature review on the epidemiology and antimicrobial resistance (AMR)…
Samsung Bioepis and Phrontline Biopharma Enter Global Collaboration to Advance Next-Generation Antibody-Drug Conjugates for Solid Tumors Samsung Bioepis Co., Ltd., a leading global biopharmaceutical company, and Phrontline Biopharma, a clinical-stage biotechnology firm pioneering a new generation of Antibody-Drug Conjugates (ADCs),…
IFF and BASF Launch Strategic Collaboration to Advance Next-Generation Enzyme and Polymer Technologies International Flavors & Fragrances Inc. (IFF), a global leader in flavors, fragrances, food ingredients, health, and biosciences, has announced a strategic collaboration with BASF, one of the…
StratifAI Selected for MSK iHub Challenge 2025 Cohort to Accelerate Polaris™ Validation Using World-Class Clinical Datasets StratifAI, the AI-driven precision oncology company behind the Polaris™ platform, today announced its selection for the prestigious Memorial Sloan Kettering (MSK) iHub Challenge 2025…
Atom Therapeutics to Present Positive Clinical Trial Data for Lead Gout Therapies at ACR Convergence 2025 Atom Therapeutics, a clinical-stage biotechnology company focused on developing innovative treatments for inflammatory and metabolic diseases, announced today that it will present two abstracts…